Cargando…

PKR: A Kinase to Remember

Aging is a major risk factor for many diseases including metabolic syndrome, cancer, inflammation, and neurodegeneration. Identifying mechanistic common denominators underlying the impact of aging is essential for our fundamental understanding of age-related diseases and the possibility to propose n...

Descripción completa

Detalles Bibliográficos
Autores principales: Gal-Ben-Ari, Shunit, Barrera, Iliana, Ehrlich, Marcelo, Rosenblum, Kobi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333748/
https://www.ncbi.nlm.nih.gov/pubmed/30686999
http://dx.doi.org/10.3389/fnmol.2018.00480
_version_ 1783387613762158592
author Gal-Ben-Ari, Shunit
Barrera, Iliana
Ehrlich, Marcelo
Rosenblum, Kobi
author_facet Gal-Ben-Ari, Shunit
Barrera, Iliana
Ehrlich, Marcelo
Rosenblum, Kobi
author_sort Gal-Ben-Ari, Shunit
collection PubMed
description Aging is a major risk factor for many diseases including metabolic syndrome, cancer, inflammation, and neurodegeneration. Identifying mechanistic common denominators underlying the impact of aging is essential for our fundamental understanding of age-related diseases and the possibility to propose new ways to fight them. One can define aging biochemically as prolonged metabolic stress, the innate cellular and molecular programs responding to it, and the new stable or unstable state of equilibrium between the two. A candidate to play a role in the process is protein kinase R (PKR), first identified as a cellular protector against viral infection and today known as a major regulator of central cellular processes including mRNA translation, transcriptional control, regulation of apoptosis, and cell proliferation. Prolonged imbalance in PKR activation is both affected by biochemical and metabolic parameters and affects them in turn to create a feedforward loop. Here, we portray the central role of PKR in transferring metabolic information and regulating cellular function with a focus on cancer, inflammation, and brain function. Later, we integrate information from open data sources and discuss current knowledge and gaps in the literature about the signaling cascades upstream and downstream of PKR in different cell types and function. Finally, we summarize current major points and biological means to manipulate PKR expression and/or activation and propose PKR as a therapeutic target to shift age/metabolic-dependent undesired steady states.
format Online
Article
Text
id pubmed-6333748
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63337482019-01-25 PKR: A Kinase to Remember Gal-Ben-Ari, Shunit Barrera, Iliana Ehrlich, Marcelo Rosenblum, Kobi Front Mol Neurosci Neuroscience Aging is a major risk factor for many diseases including metabolic syndrome, cancer, inflammation, and neurodegeneration. Identifying mechanistic common denominators underlying the impact of aging is essential for our fundamental understanding of age-related diseases and the possibility to propose new ways to fight them. One can define aging biochemically as prolonged metabolic stress, the innate cellular and molecular programs responding to it, and the new stable or unstable state of equilibrium between the two. A candidate to play a role in the process is protein kinase R (PKR), first identified as a cellular protector against viral infection and today known as a major regulator of central cellular processes including mRNA translation, transcriptional control, regulation of apoptosis, and cell proliferation. Prolonged imbalance in PKR activation is both affected by biochemical and metabolic parameters and affects them in turn to create a feedforward loop. Here, we portray the central role of PKR in transferring metabolic information and regulating cellular function with a focus on cancer, inflammation, and brain function. Later, we integrate information from open data sources and discuss current knowledge and gaps in the literature about the signaling cascades upstream and downstream of PKR in different cell types and function. Finally, we summarize current major points and biological means to manipulate PKR expression and/or activation and propose PKR as a therapeutic target to shift age/metabolic-dependent undesired steady states. Frontiers Media S.A. 2019-01-09 /pmc/articles/PMC6333748/ /pubmed/30686999 http://dx.doi.org/10.3389/fnmol.2018.00480 Text en Copyright © 2019 Gal-Ben-Ari, Barrera, Ehrlich and Rosenblum. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Gal-Ben-Ari, Shunit
Barrera, Iliana
Ehrlich, Marcelo
Rosenblum, Kobi
PKR: A Kinase to Remember
title PKR: A Kinase to Remember
title_full PKR: A Kinase to Remember
title_fullStr PKR: A Kinase to Remember
title_full_unstemmed PKR: A Kinase to Remember
title_short PKR: A Kinase to Remember
title_sort pkr: a kinase to remember
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333748/
https://www.ncbi.nlm.nih.gov/pubmed/30686999
http://dx.doi.org/10.3389/fnmol.2018.00480
work_keys_str_mv AT galbenarishunit pkrakinasetoremember
AT barrerailiana pkrakinasetoremember
AT ehrlichmarcelo pkrakinasetoremember
AT rosenblumkobi pkrakinasetoremember